CN Stock MarketDetailed Quotes

603520 Zhejiang Starry Pharmaceutical

Watchlist
  • 8.52
  • +0.21+2.53%
Market Closed Jan 21 15:00 CST
3.74BMarket Cap266.25P/E (TTM)

Zhejiang Starry Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Starry Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 3.240B--
--2024/FY-- / 2.633B--
--2023/FY2.196B / 2.437B--
--2022/FY2.131B / 2.078B--
--2021/FY2.000B / 1.950B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 3.240B--
--2024/FY-- / 2.633B--
--2023/FY2.196B / 2.437B--
--2022/FY2.131B / 2.078B--
--2021/FY2.000B / 1.950B--

Unlock Free Earnings Estimates

Zhejiang Starry Pharmaceutical Earnings Reports

  • Stary: Stelli\'s 2024 annual results forecast

    Jan 16 11:00 ET

  • Stelli\'s 2024 annual results forecast

    Jan 16 11:00 ET

  • Stari: Stari\'s report for the third quarter of 2024

    Oct 30, 2024 12:00 ET

  • Stelli\'s report for the third quarter of 2024

    Oct 30, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    HAOMIAO TECHNOLOGY
    831856
    13.12 +22.85%
    Anhui Bossco Environmental Protection Technology
    300422
    5.32 +20.09%
    MH Robot & Automation
    301199
    35.99 +20.01%
    Shanghai Hajime Advanced Material Technology
    301000
    37.79 +20.01%
    ASR Microelectronics
    688220
    64.75 +20.00%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Jan 21, 2025

    Strong Buy

    • Strong Buy

      77.78%

    • Buy

      22.22%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Specialized, Special and New
    Specialized, Special and New
    Intraday+1.12%